Back

Prediction of obstructive coronary disease : global longitudinal strain versus epicardial adipose tissue thickness

19 May 2025 (11:17 - 12:25)
Organised by: Logo
Congress Presentation Part of: ePosters in coronary artery disease (chronic) / chronic coronary syndromes (3) Nonatherosclerotic Coronary Abnormalities HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Saoussen Antit

Interior Security Forces Hospital, Tunis (Tunisia)

6 More presentations in this session

Presentation thumbnail
The portuguese perspective on the management of MINOCA patients
Doctor M. Figueiredo (Barreiro, PT)
Abstract Slides Video
Presentation thumbnail
The impact of ABCDE stress echocardiography results with exercise on the management of patients with diabetes mellitus and coronary artery disease
Doctor D. Abdulloev (Dushanbe, TJ)
Abstract Slides Video
Presentation thumbnail
Prevalence of coronary artery anomalies using angio-CT in patients with preserved heart failure
Doctor E. Shirka (Tirana, AL)
Abstract Slides Video
Presentation thumbnail
Exploring gender differences in secondary prevention outcomes after acute coronary syndrome
Doctor M. Leite (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Myocardial bridging analysis in patients with heart failure with preserved ejection fraction
Doctor E. Shirka (Tirana, AL)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in coronary artery disease (chronic) / chronic coronary syndromes (3)

The Event

Event poster

Heart Failure 2025

19 May 2025 11:17 CET
You may be interested in
thumbnail
Congress Presentation
Echocardiographic predictors for chronic coronary artery disease in patients with ST-T alterations
thumbnail
Congress Presentation
Refining coronary artery disease detection: integrating left ventricular longitudinal strain and high-sensitivity C-reactive protein for risk stratification
thumbnail
Congress Presentation
Epicardial adipose tissue volume is related to subclinical atherosclerosis and major adverse cardiac events in asymptomatic subjects

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources